1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Generics

AAM Calls For Congress And FDA To End Shortages By Easing Up On Generics Quality, Pricing

 
• By Bowman Cox

Remote inspection alternatives could allow quicker resolution of quality issues that are holding up US imports, says association for generic drug manufacturers. AAM adds that adjusting a Medicaid inflation penalty could relieve unfair price pressures.

Empty bottles and a lonely generic pill
what would bring generics sector quick relief? • Source: Shutterstock

The government should reduce shortages of generic drugs by ensuring speedier resolution of regulatory issues like quality problems and providing for higher, more stable pricing, suggests a recent white paper from the US association for generic drug manufacturers.

The Association for Accessible Medicines complained that FDA warning letters concerning manufacturing quality concerns can lead to delays, shutdowns and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Biosimilars & Generics